Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients
A clinical trial involving over 500 adults diagnosed with schizophrenia has found that by adding the drug samidorphan to the antipsychotic medicine olanzapine, it was possible to substantially reduce… Read More
Researchers Identify Sensory Neurons in the Gut That Signal the Brain to Stop Eating
New research has revealed specific types of neurons that control eating behavior. This basic research about how the body and brain work together has important implications for obesity and metabolic… Read More
Large Genome Study Suggests Anorexia Nervosa is a Metabolic Disorder as Well as a Psychiatric One
By far the largest genetic study to date of anorexia nervosa has identified eight areas in the human genome in which DNA variations are likely to contribute to risk for the illness. Even more… Read More
Relief from Decades of Treatment-Resistant Depression Comes with Metabolite Replacement Therapy Trial
Bruce had tried everything. And yet, for three decades, he could not find any relief from his debilitating depression and suicidal thoughts. Twenty medications. Electroconvulsive therapy. Countless… Read More
Relieving Treatment – Resistant Depression by Treating Metabolic Deficiencies
An important discovery has been made at the University of Pittsburgh. It raises the prospect that there may be an entirely new way of relieving major depression in people who repeatedly have failed… Read More